Stocksigma LogoStocksigma Logo

EP Biocomposites Reports H1 FY27 Results and Annual Outlook

For the half-year ended 30th Sep'26, EP Biocomposites reported revenue from operations of ₹295.38 lakhs, down 27.5% YoY from ₹407.48 lakhs, and recorded

EP Biocomposites Reports H1 FY27 Results and Annual Outlook

EP Biocomposites Ltd · Financial Result · 13 Nov 2026, 11:31 pm

EP Biocomposites Reports H1 FY27 Results and Annual Outlook For the half-year ended 30th Sep'26, EP Biocomposites reported revenue from operations of ₹295.38 lakhs, down 27.5% YoY from ₹407.48 lakhs, and recorded its first post-listing net loss of ₹43.40 lakhs versus a ₹9.04 lakhs profit in H1 FY26. Diluted EPS stood at -₹2.58. Higher employee expenses for expansion impacted profitability. Despite the weak first half, management expects full-year revenue to reach approximately ₹16.00 crore (>15% YoY growth), supported by ₹5.74 crore in orders in hand and ₹7.00 crore in expected orders.

Original exchange filing (PDF)

More announcements from EP Biocomposites Ltd

All EP Biocomposites Ltd announcements